Optic IconOptic Logo
|
SearchCollectionsBenchmarks
Organization

Daiichi Sankyo Ltd.

1 abstract

Abstract
A phase 1b, multicenter, open-label study of valemetostat in combination with DXd antibody drug conjugates (ADCs), trastuzumab deruxtecan (T-DXd) or datopotamab deruxtecan (Dato-DXd), in patients with solid tumors.
Org: National Cancer Center East, Daiichi Sankyo Ltd.,